Показано 0 из 0
Дата |
---|
03.05.2024 |
02.05.2024 |
30.04.2024 |
29.04.2024 |
26.04.2024 |
25.04.2024 |
24.04.2024 |
23.04.2024 |
22.04.2024 |
19.04.2024 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
---|---|---|---|---|---|---|---|
0.484
|
0.595
|
0.535
|
0.535
|
0.535
|
0.535
|
|
|
|
|
0.464
|
0.59
|
0.535
|
0.535
|
0.535
|
0.535
|
|
|
|
|
0.464
|
0.58
|
0.565
|
0.565
|
0.565
|
0.565
|
|
|
|
|
0.496
|
0.605
|
0.58
|
0.58
|
0.58
|
0.58
|
|
|
|
|
0.50
|
0.62
|
0.59
|
0.59
|
0.59
|
0.59
|
|
|
|
|
0.52
|
0.635
|
0.59
|
0.59
|
0.59
|
0.59
|
|
|
|
|
0.53
|
0.63
|
0.605
|
0.605
|
0.605
|
0.605
|
|
|
|
|
0.56
|
0.675
|
0.565
|
0.565
|
0.565
|
0.565
|
|
|
|
|
0.525
|
0.645
|
0.474
|
0.474
|
0.474
|
0.474
|
|
|
|
|
0.434
|
0.545
|
0.45
|
0.45
|
0.45
|
0.45
|
|
|
|
|
Kineta, Inc. is a clinical-stage bio-pharmaceutical company. The Company focuses on the discovery and development of adaptive immunity and T cell therapies for the treatments for neuro-degenerative diseases. Kineta operates in the United States.